X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (336) 336
Book Chapter (32) 32
Patent (15) 15
Book / eBook (4) 4
Conference Proceeding (3) 3
Publication (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (204) 204
life sciences & biomedicine (135) 135
science & technology (135) 135
surgery (129) 129
cardiovascular system & cardiology (109) 109
peripheral vascular disease (104) 104
male (90) 90
female (86) 86
treatment outcome (74) 74
aged (68) 68
middle aged (68) 68
cardiology and cardiovascular medicine (62) 62
adult (51) 51
abridged index medicus (42) 42
risk factors (33) 33
time factors (32) 32
anticoagulants - therapeutic use (30) 30
thrombolytic therapy (30) 30
aged, 80 and over (26) 26
venous thrombosis - therapy (26) 26
retrospective studies (25) 25
care and treatment (24) 24
prospective studies (24) 24
quality of life (23) 23
risk assessment (22) 22
thrombolytic therapy - methods (21) 21
acute disease (20) 20
leg - blood supply (19) 19
anticoagulants (18) 18
fibrinolytic agents - administration & dosage (18) 18
follow-up studies (18) 18
united states (18) 18
venous thrombosis - complications (18) 18
venous thrombosis - drug therapy (18) 18
fibrinolytic agents - therapeutic use (17) 17
postthrombotic syndrome - etiology (17) 17
stents (17) 17
thrombosis (17) 17
venous thrombosis (17) 17
postthrombotic syndrome - prevention & control (16) 16
severity of illness index (16) 16
thromboembolism (16) 16
devices for introducing media into, or onto, the body (15) 15
devices for producing or ending sleep or stupor (15) 15
devices for transducing body media or for taking media fromthe body (15) 15
human necessities (15) 15
hygiene (15) 15
medical or veterinary science (15) 15
patient selection (15) 15
phlebography (15) 15
analysis (14) 14
cardiac & cardiovascular systems (14) 14
chronic disease (14) 14
ischemia (13) 13
vascular surgical procedures (13) 13
deep vein thrombosis (12) 12
deep venous thrombosis (12) 12
evidence-based medicine (12) 12
femoral vein (12) 12
thrombophlebitis (12) 12
ultrasonography, doppler, duplex (12) 12
femoral vein - surgery (11) 11
general & internal medicine (11) 11
iliac vein (11) 11
postthrombotic syndrome (11) 11
pulmonary embolism - prevention & control (11) 11
radiography (11) 11
thrombolytic therapy - adverse effects (11) 11
blood vessel prosthesis (10) 10
combined modality therapy (10) 10
diagnosis (10) 10
health aspects (10) 10
iliac vein - surgery (10) 10
methods (10) 10
thrombectomy (10) 10
ultrasonography (10) 10
vascular patency (10) 10
venous insufficiency - physiopathology (10) 10
venous thrombosis - diagnostic imaging (10) 10
venous thrombosis - physiopathology (10) 10
venous thrombosis - prevention & control (10) 10
venous thrombosis - surgery (10) 10
aortic aneurysm, abdominal - surgery (9) 9
catheterization, peripheral (9) 9
exercise (9) 9
fibrinolytic agents - adverse effects (9) 9
hematology (9) 9
incidence (9) 9
pulmonary embolism (9) 9
randomized controlled trials as topic (9) 9
regional blood flow (9) 9
thrombolysis (9) 9
venous insufficiency (9) 9
venous thrombosis - diagnosis (9) 9
blood vessels (8) 8
catheter-directed thrombolysis (8) 8
endarterectomy (8) 8
intermittent claudication - therapy (8) 8
lower extremity - blood supply (8) 8
medicine, general & internal (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2017, Volume 377, Issue 23, pp. 2240 - 2252
Journal Article
2014, Practical phlebology, ISBN 1444146092, xvii, 131
"This essential volume from the series provides trainee and practicing phlebologists with the ideal illustrative guide to the etiology, diagnosis, and... 
Venous Thrombosis | Thrombophlebitis | Thromboembolism | Thrombosis
Book
Journal Article
Journal Article